menu
    • menu

    Company profile for OncoHost

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OncoHost™ is developing cutting-edge technology to characterize, analyze, and predict patient response to treatment, enabling personalized treatment strategies with improved outcomes & reduced side effects. OncoHost develops personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, we aim to understand patient's unique response to therapy and overcome one of the major obstac...
    OncoHost™ is developing cutting-edge technology to characterize, analyze, and predict patient response to treatment, enabling personalized treatment strategies with improved outcomes & reduced side effects. OncoHost develops personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, we aim to understand patient's unique response to therapy and overcome one of the major obstacles in clinical oncology today – resistance to therapy. Based on robust scientific infrastructure & a strong IP position, OncoHost is launching an extensive clinical program with leading academic/clinical partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OncoHostIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    P.O.Box 446, 3 Hamelacha, Binyamina
    Telephone
    Telephone
    +972 52 333 5429
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://oncohost.com/
    Linkedin
    Linkedin
    https://ca.linkedin.com/company/oncohost
    youtube
    YouTube
    Twitter
    Twitter
    https://mobile.x.com/OncoHost

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncohost To Unveil Proteomic Aging Biomarkers Research At AACR
    Oncohost To Unveil Proteomic Aging Biomarkers Research At AACR

    15 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncohost-to-present-new-research-on-proteomic-aging-biomarkers-outcomes-at-aacr-2026-302742971.html

    PR NEWSWIRE
    15 Apr 2026
    Share Share
    Oncohost Wins 2026 AI Excellence Award In Health Category
    Oncohost Wins 2026 AI Excellence Award In Health Category

    24 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncohost-wins-2026-artificial-intelligence-excellence-award-in-health-category-302723286.html

    PR NEWSWIRE
    24 Mar 2026
    Share Share
    Oncohost Unveils Breakthrough Study In JPBA On Serum-Plasma
    Oncohost Unveils Breakthrough Study In JPBA On Serum-Plasma

    18 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncohost-publishes-landmark-study-in-jpba-demonstrating-serumplasma-proteomic-bridging-expanding-biomarker-research-capabilities-302691447.html

    PR NEWSWIRE
    18 Feb 2026
    Share Share
    OncoHost Named Top 10 Small Biz Innovator in 2026 BIG Awards
    OncoHost Named Top 10 Small Biz Innovator in 2026 BIG Awards

    15 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncohost-wins-2026-big-innovation-award-in-health-category-named-a-top-10-innovator--small-business-302662330.html

    PR NEWSWIRE
    15 Jan 2026
    Share Share
    Oncohost Wins Gold In 2025 Healthcare Tech Solution Awards
    Oncohost Wins Gold In 2025 Healthcare Tech Solution Awards

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncohost-named-gold-winner-in-2025-merit-awards-for-healthcare--technology-solution-of-the-year-302633019.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    OncoHost Wins Top Proteomics Award at BioTech Gala
    OncoHost Wins Top Proteomics Award at BioTech Gala

    06 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncohost-wins-proteomics-innovation-of-the-year-at-the-biotech-breakthrough-awards-302607076.html

    PR NEWSWIRE
    06 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search